Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
|
|
33.
|
|
|
34.
|
|
|
35.
|
|
|
36.
|
|
|
37.
|
Prevention of vascular damage in scleroderma and autoimmune Raynaud's phenomenon: a multicenter, randomized, double-blind, placebo-controlled trial of the angiotensin-converting enzyme inhibitor quinapril. [electronic resource] by
- Gliddon, A E
- Doré, C J
- Black, C M
- McHugh, N
- Moots, R
- Denton, C P
- Herrick, A
- Barnes, T
- Camilleri, J
- Chakravarty, K
- Emery, P
- Griffiths, B
- Hopkinson, N D
- Hickling, P
- Lanyon, P
- Laversuch, C
- Lawson, T
- Mallya, R
- Nisar, M
- Rhys-Dillon, C
- Sheeran, T
- Maddison, P J
Producer: 20071219
In:
Arthritis and rheumatism vol. 56
Availability: No items available.
|